Lipitor, Atorvastatin

Lipitor, Atorvastatin Newswire (Page 5)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 5)

Results 81 - 100 of 2,065 in Lipitor, Atorvastatin (generic)

  1. DSM cuts out China's ATS-8 intermediate middlemen with enzyme-made statin APIsRead the original story w/Photo

    Oct 14, 2014 | Drug Researcher

    Royal DSM has launched a statin API it claims is made using a green production method that reduces reliance on intermediate suppliers. The new active pharmaceutical ingredient is a version of rosuvastatin, the active in AstraZeneca's Crestor, that is produced using an enzymatic process that requires fewer solvents, and eliminates buthyl-lithuim entirely.

    Comment?

  2. Major health campaign starts to tackle one of Bradford's biggest killersRead the original story w/Photo

    Oct 16, 2014 | Thetelegraphand Argus

    A MAJOR campaign to help tackle the one of the biggest killers in Bradford has been announced by health leaders. Bradford's Healthy Hearts project has been developed to reduce the risk of stroke and heart attack in people who are considered to be at risk.

    Comment?

  3. Atorvastatin Reduces the Proadhesive and Prothrombotic Endothelial...Read the original story

    Oct 15, 2014 | Circulation

    From the Hematology-Oncology Department, Faculty of Medicine and Pharmacy Department, Chemistry Faculty , Pontificia Universidad CatA3lica de Chile, Santiago, Chile; and Nuclear Medicine Section, Medicine Department, University of Chile Clinical Hospital, Santiago, Chile . Correspondence to Jaime Pereira, MD, Department of Hematology-Oncology, School of Medicine, Pontificia Universidad CatA3lica de Chile, Santiago, Chile.

    Comment?

  4. Chemically induced mouse liver tumors are resistant to treatment with atorvastatinRead the original story

    Oct 15, 2014 | BioMed Central

    Atorvastatin is a potent inhibitor of the mevalonate pathway and widely used as a hypolipidemic drug. Some epidemiological studies and animal experiments indicate that the long-term use of atorvastatin and structurally related drugs might be associated with a reduced risk of developing hepatocellular carcinoma , the most common hepatocellular malignancy in humans.

    Comment?

  5. DSM cuts out China's ATS-8 intermediate middlemen with enzyme-made statin APIsRead the original story w/Photo

    Oct 14, 2014 | In-PharmaTechnologist.com

    Royal DSM has launched a statin API it claims is made using a green production method that reduces reliance on intermediate suppliers. The new active pharmaceutical ingredient is a version of rosuvastatin, the active in AstraZeneca's Crestor, that is produced using an enzymatic process that does not require solvents.

    Comment?

  6. Canada pays too much for generic drugs: studyRead the original story w/Photo

    Oct 14, 2014 | Barriere Star Journal

    Canada is still paying far more than other industrialized countries for generic drugs, despite recent efforts by the provinces and territories to cuts costs by bulk-buying six particularly costly medications, a new study has found. The study by the University of Ottawa and the Bruyere Research Institute says the price tags on the six drugs - which include medications for high blood pressure and high cholesterol - remain much higher in Canada than they are elsewhere.

    Comment?

  7. Canadians In Distress As Essential Generic Drug Prices Are SoaringRead the original story w/Photo

    Oct 14, 2014 | International Business Times

    Canada is facing a serious problem of escalating prices of generic drugs that are 60 to 70 percent cheaper in other industrialised countries. The problem is more acute in the case of six essential drugs.

    Comment?

  8. Ontario health minister pledges review of generic drug costsRead the original story w/Photo

    Oct 14, 2014 | The Toronto Star

    Ontario Health Minister Eric Hoskins has asked his ministry to review a new study showing Canada pays more than double for common generic drugs compared to other developed countries. Health critics have called for a review of the purchasing system for the drugs in the wake of the study, published Tuesday.

    Comment?

  9. Provinces overpay for generic drugs, study findsRead the original story w/Photo

    Oct 14, 2014 | CBC News

    University of Ottawa associate professor Amir Attaran is co-author of a study of how much countries pay for generic drugs. Canada pays too much, he says.

    Comment?

  10. Canadians still paying too much for generic drugs: studyRead the original story w/Photo

    Oct 14, 2014 | CTV

    Canada is still paying far more than other industrialized countries for generic drugs, despite recent efforts by the provinces and territories to cuts costs by bulk-buying six particularly costly medications, a new study has found. The study by the University of Ottawa and the Bruyere Research Institute says the price tags on the six drugs -- which include medications for high blood pressure and high cholesterol -- remain much higher in Canada than they are elsewhere.

    Comment?

  11. Canadians paying more than double for certain generic drugs: StudyRead the original story w/Photo

    Oct 14, 2014 | CNews

    Canadians are paying more than double what other developed nations pay for generic drugs because of this country's "highly unusual" approach to pricing, a new study has found. In April 2013, Canada's premiers, under the auspices of the Council of the Federation, came to an agreement to reduce the maximum price for six commonly used generics to 18% of the price of the brand-name versions.

    Comment?

  12. A Quick Look at Pfizer Inc.'s Drug Development PipelineRead the original story w/Photo

    Oct 14, 2014 | The Motley Fool

    The stock market offers plenty of industries for investors to choose from, but when it comes to looking deep into the future and basing a company's valuation more on promise than on its present-day products, healthcare takes the cake. Pharmaceutical companies, for example, are substantially reliant on their drug development pipeline to fuel future growth.

    Comment?

  13. Is it true that below 70 LDL, cholesterol deposits recede?Read the original story w/Photo

    Oct 14, 2014 | Ask MetaFilter

    A friend just had a stent put in due to 100% congestion in one blood vessel . He's on highest Lipitor dose , which has brought LDL down to 90. Cardiologist wants to keep him on high Lipitor plus sign him up for a trial of Alirocumab .

    Comment?

  14. Canadians' generic-drug costs too high, study saysRead the original story w/Photo

    Oct 14, 2014 | Globe and Mail

    Bottles of Atorvastatin Calcium tablets, a generic form of Lipitor, are shown in an undated photo. A new study has found that Canadians are still paying far more than other industrialized countries for generic drugs, despite recent efforts by the provinces and territories to bulk buy six particularly costly medications.

    Comment?

  15. DSM cuts out ATS-8 intermediate middlemen with enzyme-made statin APIsRead the original story w/Photo

    Oct 14, 2014 | In-PharmaTechnologist.com

    Royal DSM has launched a range of statin APIs that it claims are made using a greener production method that reduces reliance on intermediate suppliers. The new active pharmaceutical ingredients -launched at CPhI in Paris, France last week - are part of DSM's "PureActives" range, which are made using an enzymatic process that does not require solvents.

    Comment?

  16. Canada paying more than double for common generic drugs, study saysRead the original story w/Photo

    Oct 14, 2014 | The Toronto Star

    Canada is paying more than double for six commonly used generic drugs compared with other developed countries because of a “highly unusual” purchasing plan, according to a new study released Tuesday. Researchers found that through a mix of negotiations with drug companies and calls for tender, countries such as New Zealand, the United Kingdom and Germany are paying less than Canada for generic medications that treat everything from high blood pressure to depression.

    Comment?

  17. Lipitor Lawsuits Move Forward, as Pfizer Seeks Dismissal of Texas...Read the original story

    Oct 13, 2014 | Personal Injury Law News

    The Firm is evaluating Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to their use of the cholesterol-lowering statin medication. 2 comments

  18. Foreign pharmacy marketing to Mainers is illegal, unsafe - and not a better dealRead the original story w/Photo

    Oct 13, 2014 | Bangor Daily News

    We are disappointed to hear of another foreign entity trying to skirt U.S. federal law and market prescription drugs to Maine residents. As the BDN reported in an Oct. 7 article , Great British Drug Store will begin offering online drugs.

    Comment?

  19. High Cholesterol Tied to Prostate Cancer's Return in StudyRead the original story w/Photo

    Oct 10, 2014 | MedlinePlus

    After surgery for prostate cancer, elevated levels of cholesterol and triglycerides may be linked with greater risk of the cancer's return, a new study suggests. In a review of more than 800 men who had had their prostate gland removed, those with higher levels of these two blood fats were more likely to have their cancer come back, compared with men with normal levels.

    Comment?

  20. Adherence Challenges for a Patient with Type 2 Diabetes MellitusRead the original story

    Oct 10, 2014 | Pharmacy Times

    Brown bag consults for patients living with chronic diseases do not have to be time-consuming or even scheduled. Consults can simply be offered to select patients who you feel need follow-up care after a counseling session.

    Comment?